tiprankstipranks

Daniel Lynch Insider Profile

4 Followers
Daniel Lynch, Director at Carisma Therapeutics, holds 161.43K shares in Carisma Therapeutics (Ticker: CARM), holds ― shares in Surface Oncology (Ticker: SURF), holds ― shares in Translate Bio (Ticker: ~TBIO).
tipranks
Daniel Lynch

Daniel Lynch
Carisma Therapeutics (CARM)
Director

Not Ranked
Daniel Lynch has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$27M
50.14%
48.63%
0.84%
0.35%
0.03% Others
A breakdown of Daniel Lynch's holdings

Insider Roles

Springworks Therapeutics
(SWTX)
Director
Blueprint Medicines
(BPMC)
Director
Carisma Therapeutics
(CARM)
Director
2seventy bio
(TSVT)
Director
+1 other positions
Roles that Daniel Lynch holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Daniel Lynch

Daniel Lynch's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Carisma Therapeutics
Feb 13, 2014
Director
Uninformative Buy
$227.62K
SURF
Surface Oncology
~TBIO
Translate Bio
Springworks Therapeutics
May 17, 2024
Director
Uninformative Buy
$13.54M
2seventy bio
Jun 15, 2023
Director
Uninformative Buy
$95.79K
Bluebird Bio
Jun 17, 2021
Director
Uninformative Buy
$7.82K
BINDQ
DNIB Unwind, Inc.
Aug 30, 2016
Informative Buy
8.80K
$0.00
Blueprint Medicines
Jun 26, 2020
Director
Uninformative Buy
$13.14M
List of latest transactions for each holding click on a transaction to see Daniel Lynch's performance on stock

Daniel Lynch insider profile FAQ

What is the percentage of profitable transactions made by Daniel Lynch?
The percentage of profitable transactions made by Daniel Lynch is ―.
    What is the average return per transaction made by Daniel Lynch?
    The average return per transaction made by Daniel Lynch is ―.
      What stocks does Daniel Lynch hold?
      Daniel Lynch holds: CARM, SURF, ~TBIO, SWTX, TSVT, BLUE, BINDQ, BPMC stocks.
        What was Daniel Lynch’s latest transaction?
        Daniel Lynch latest transaction was an Uninformative Buy of ―.
          What was Daniel Lynch's most profitable transaction?
          Daniel Lynch’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Daniel Lynch's role in Carisma Therapeutics?
            Daniel Lynch's role in Carisma Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.